• 4698 Citations
  • 38 h-Index
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1980 2019

2019

An elective course in lesbian, gay, bisexual, and transgender health and practice issues

Jann, M. W., Penzak, S., White, A. & Tatachar, A., 1 Jan 2019, In : American journal of pharmaceutical education. 83, 8, p. 1723-1731 9 p., 6967.

Research output: Contribution to journalArticle

Transgender Persons
Health
health
health care
learning
2 Citations (Scopus)

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.

Research output: Contribution to journalReview article

Serotonin Uptake Inhibitors
Hemorrhage
clopidogrel
Gastrointestinal Tract
Osteopathic Physicians

The Evolving Role of Pharmacists in Transgender Health Care

Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.

Research output: Contribution to journalReview article

Open Access
Transgender Persons
pharmacist
Pharmacists
health care
Delivery of Health Care
2018
Antipsychotic Agents
Injections
Pharmaceutical Preparations
Schizophrenia
Pharmacokinetics
10 Citations (Scopus)

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Injections
olanzapine
Risperidone
Patient Education
2016

Anesthetic drugs pharmacokinetics and pharmacodynamics

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 373-394 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ketamine
Anesthetics
Cytochrome P-450 CYP3A
Thiopental
Anesthesia

Anti-addiction agents

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 351-372 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Opiate Alkaloids
Naloxone
Tobacco Use Disorder
Naltrexone
Pharmacokinetics
1 Citation (Scopus)

Antidementia drugs

van Den Berg, C. M. & Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 329-349 21 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Memantine
Cholinesterase Inhibitors
Alzheimer Disease
Rivastigmine
Pharmacokinetics
2 Citations (Scopus)

Antipsychotics

Jann, M. W. & Klugh Kennedy, W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 139-175 37 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Antipsychotic Agents
Pharmacokinetics
Schizophrenia
Dopamine Receptors
Cholinergic Antagonists
2 Citations (Scopus)
Pharmacokinetics
Drug Interactions
Pharmaceutical Preparations
Patient Care
Central Nervous System Agents
2 Citations (Scopus)

Clinically significant interactions with anesthetic agents

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 579-601 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Midazolam
Anesthetics
Drug Interactions
Ketamine
Alfentanil

Clinical pharmacokinetics and pharmacodynamics of psychopharmacological drug classes

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, 1 p.

Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

Pharmacokinetics
Pharmaceutical Preparations

Preface

Jann, M. W., Penzak, S. R. & Cohen, L. J., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. v-vi

Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

2015
21 Citations (Scopus)
Drug interactions
Tandem Mass Spectrometry
Chromatography
Drug Interactions
Mass spectrometry
2014
109 Citations (Scopus)

Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics

Jann, M., Kennedy, W. K. & Lopez, G., Feb 2014, In : Journal of Pharmacy Practice. 27, 1, p. 5-16 12 p.

Research output: Contribution to journalArticle

Drug Overdose
Prescription Drugs
Benzodiazepines
Opioid Analgesics
Oxycodone
33 Citations (Scopus)
Bipolar Disorder
Therapeutics
Bipolar disorder
Antipsychotic Agents
Second-Generation Antidepressive Agents
1 Citation (Scopus)

Unique collaboration between a private college of pharmacy and a private academic health system

Metzger, N., Paciullo, C., Chesson, M., Jann, M. W., Glascock, J., Emamifar, A. & Matthews, H. W., 1 Jan 2014, In : Hospital Pharmacy. 49, 7, p. 634-638 5 p.

Research output: Contribution to journalArticle

Health
Students
Education
Hospital Pharmacy Services
Pharmacy Students
2013
44 Citations (Scopus)

Clinically significant drug interactions with atypical antipsychotics

Kennedy, W. K., Jann, M. W. & Kutscher, E. C., 1 Dec 2013, In : CNS Drugs. 27, 12, p. 1021-1048 28 p.

Research output: Contribution to journalReview article

Drug Interactions
Antipsychotic Agents
Pharmaceutical Preparations
Anticonvulsants
Pharmacokinetics
38 Citations (Scopus)
Warfarin
Metabolites
Tandem Mass Spectrometry
Chromatography
Mass spectrometry
2012
7 Citations (Scopus)

Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir

Jann, M. W., Spratlin, V., Momary, K., Zhang, H., Turner, D., Penzak, S. R., Wright, A. & VanDenBerg, C., 1 May 2012, In : European Journal of Clinical Pharmacology. 68, 5, p. 715-721 7 p.

Research output: Contribution to journalArticle

Indinavir
Drug Interactions
Pharmacokinetics
Pharmaceutical Preparations
Antidepressive Agents
2011
7 Citations (Scopus)

Advanced strategies for treatment of Parkinson's disease: the role of early treatment.

Jann, M. W., 1 Jan 2011, In : The American journal of managed care. 17 Suppl 12

Research output: Contribution to journalReview article

Parkinson Disease
Levodopa
Monoamine Oxidase Inhibitors
Activities of Daily Living
Therapeutics
177 Citations (Scopus)

Maternal treatment with opioid analgesics and risk for birth defects

Broussard, C. S., Rasmussen, S. A., Reefhuis, J., Friedman, J. M., Jann, M. W., Riehle-Colarusso, T. & Honein, M. A., 1 Jan 2011, In : American Journal of Obstetrics and Gynecology. 204, 4, p. 314.e1-314.e11

Research output: Contribution to journalArticle

Opioid Analgesics
Odds Ratio
Mothers
Therapeutics
Women Physicians
2008
4 Citations (Scopus)

Disposition of D-serine in healthy adults

Tsai, G. E., Lane, H. Y., Vandenberg, C. M., Liu, Y. C., Tsai, P. & Jann, M. W., 1 Apr 2008, In : Journal of Clinical Pharmacology. 48, 4, p. 524-527 4 p.

Research output: Contribution to journalArticle

Nonlinear Dynamics
Statistical Models
Tissue Distribution
N-Methylaspartate
Biotransformation
2007
124 Citations (Scopus)

Antidepressant agents for the treatment of chronic pain and depression

Jann, M. W. & Slade, J. H., 1 Nov 2007, In : Pharmacotherapy. 27, 11, p. 1571-1587 17 p.

Research output: Contribution to journalReview article

Chronic Pain
Antidepressive Agents
Depression
Pain
Therapeutics
2006
8 Citations (Scopus)

Altered methylprednisolone pharmacodynamics in healthy subjects with Histamine N-Methyltransferase C314T genetic polymorphism

Yuen, Y. H., Jusko, W. J., Spratlin, V. E. & Jann, M. W., 1 Apr 2006, In : Journal of Clinical Pharmacology. 46, 4, p. 408-417 10 p.

Research output: Contribution to journalArticle

Histamine N-Methyltransferase
Methylprednisolone
Genetic Polymorphisms
Healthy Volunteers
Genotype
2 Citations (Scopus)

Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells

Matesic, D. F., Abifadel, D. N., Garcia, E. L. & Jann, M. W., 1 Jul 2006, In : Cell Biology and Toxicology. 22, 4, p. 257-268 12 p.

Research output: Contribution to journalArticle

Thioridazine
Connexin 43
Gap Junctions
Mesoridazine
Communication
6 Citations (Scopus)

Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes: A pilot study

Yuen, Y. H., Jusko, W. J., Zhou, H. H., Chen, G. L., Guo, D., Zhou, G., Spratlin, V. E. & Jann, M. W., 9 May 2006, In : Molecular Diagnosis and Therapy. 10, 2, p. 109-114 6 p.

Research output: Contribution to journalArticle

Histamine N-Methyltransferase
Histamine
Hydrocortisone
Genotype
Heterozygote

Galantamine extended release: A veiwpoint

Farlow, M. R., Jann, M. W., Lyketsos, C. G. & Kozauer, N. A., 3 Aug 2006, In : CNS Drugs. 20, 8, p. 682-683 2 p.

Research output: Contribution to journalComment/debate

Galantamine
15 Citations (Scopus)

Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers

Jann, M. W., Hon, Y. Y., Shamsi, S. A., Zheng, J., Awad, E. A. & Spratlin, V., 1 May 2006, In : Pharmacotherapy. 26, 5 I, p. 627-633 7 p.

Research output: Contribution to journalArticle

olanzapine
Healthy Volunteers
Pharmacokinetics
Bipolar Disorder
lamotrigine
11 Citations (Scopus)

Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition

Lee, S. J., Jusko, W. J., Salaita, C. G., Calis, K. A., Jann, M. W., Spratlin, V. E., Goldstein, J. A. & Yuen, Y. H., 1 May 2006, In : Journal of Clinical Pharmacology. 46, 5, p. 515-526 12 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP3A
Methylprednisolone
Healthy Volunteers
Alleles
Diet
2004
42 Citations (Scopus)

Development of capillary zone electrophoresis-electrospray ionization-mass spectrometry for the determination of lamotrigine in human plasma

Zheng, J., Jann, M. W., Hon, Y. Y. & Shamsi, S. A., 1 Jul 2004, In : Electrophoresis. 25, 13, p. 2033-2043 11 p.

Research output: Contribution to journalArticle

Plasma (human)
Electrospray ionization
Electrospray Ionization Mass Spectrometry
Capillary Electrophoresis
Electrophoresis
20 Citations (Scopus)

Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia

Chiu, C. C., Lane, H. Y., Huang, M. C., Liu, H. C., Jann, M. W., Hon, Y. Y., Chang, W. H. & Lu, M. L., 1 Dec 2004, In : Journal of Clinical Pharmacology. 44, 12, p. 1385-1390 6 p.

Research output: Contribution to journalArticle

olanzapine
Fluvoxamine
Schizophrenia
Pharmacokinetics
Cytochromes
38 Citations (Scopus)

Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis

Jann, M. W., 1 Dec 2004, In : Pharmacotherapy. 24, 12 I, p. 1759-1783 25 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Schizophrenia
Prefrontal Cortex
Catechol O-Methyltransferase
Dopamine
2003
49 Citations (Scopus)

Correlation of cytochrome p450 (CYP) ia2 activity using caffeine phenotyping and olanzapine disposition in healthyvolunteers

Shirley, K. L., Hon, Y. Y., Penzak, S. R., Francis Lam, Y. W., Spratlin, V. & Jann, M. W., May 2003, In : Neuropsychopharmacology. 28, 5, p. 961-966 6 p.

Research output: Contribution to journalArticle

olanzapine
Caffeine
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP1A2
Saliva
2002
253 Citations (Scopus)

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

Jann, M. W., Shirley, K. L. & Small, G. W., 1 Jan 2002, In : Clinical Pharmacokinetics. 41, 10, p. 719-739 21 p.

Research output: Contribution to journalReview article

Cholinesterase Inhibitors
Rivastigmine
Pharmacokinetics
Galantamine
Tacrine
7 Citations (Scopus)

Clinical significance of drug binding, protein binding, and binding displacement drug interactions

Jann, M. W., 1 Jun 2002, In : Psychopharmacology bulletin. 36, 3, p. 22-41 20 p.

Research output: Contribution to journalArticle

Drug Interactions
Protein Binding
Antipsychotic Agents
Carrier Proteins
olanzapine
9 Citations (Scopus)

Dosing strategies of clozapine-fluvoxamine cotreatment [4]

Lu, M. L., Lane, H. Y., Jann, M. W. & Chang, W. H., 1 Dec 2002, In : Journal of Clinical Psychopharmacology. 22, 6, p. 626-628 3 p.

Research output: Contribution to journalLetter

Second-Generation Antidepressive Agents
Fluvoxamine
Clozapine
Combination Drug Therapy
Antipsychotic Agents
37 Citations (Scopus)

Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics

Penzak, S. R., Acosta, E. P., Turner, M., Edwards, D. J., Hon, Y. Y., Desai, H. D. & Jann, M. W., 1 Oct 2002, In : Journal of Clinical Pharmacology. 42, 10, p. 1165-1170 6 p.

Research output: Contribution to journalArticle

Indinavir
Citrus paradisi
Pharmacokinetics
Cytochrome P-450 CYP3A
Cross-Over Studies
38 Citations (Scopus)

Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers

Penzak, S. R., Hon, Y. Y., Lawhorn, W. D., Shirley, K. L., Spratlin, V. & Jann, M. W., 5 Aug 2002, In : Journal of Clinical Psychopharmacology. 22, 4, p. 366-370 5 p.

Research output: Contribution to journalArticle

olanzapine
Ritonavir
Healthy Volunteers
Pharmacokinetics
HIV Protease Inhibitors
12 Citations (Scopus)

Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype

Jann, M. W., ZumBrunnen, T. L., Kazmi, Y. R., VanDenBerg, C. M., Desai, H. D., Weidler, D. J. & Flockhart, D. A., 9 Oct 2002, In : Drug Metabolism and Drug Interactions. 19, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

Fluvoxamine
Pharmacokinetics
Genotype
Phenotype
Cytochrome P-450 CYP2D6
2001

Contemporary drug treatment

Corey-Bloom, J., Geldmacher, D. S. & Jann, M. W., 15 Feb 2001, In : Patient Care. 35, 3, p. 54-67 14 p.

Research output: Contribution to journalArticle

Cholinesterases
Dementia
Alzheimer Disease
Pharmaceutical Preparations
2 Citations (Scopus)

Differences in haloperidol epidemiologic pharmacokinetic studies [9]

Jann, M. W., Chang, W. H. & Lane, H. Y., 17 Dec 2001, In : Journal of Clinical Psychopharmacology. 21, 6, p. 628-630 3 p.

Research output: Contribution to journalLetter

Haloperidol
Psychotic Disorders
Cytochrome P-450 Enzyme System
Antipsychotic Agents
Isoenzymes
13 Citations (Scopus)

Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo

Lane, H. Y., Chiu, C. C., Kazmi, Y., Desai, H., Francis Lam, Y. W., Jann, M. W. & Chang, W. H., 1 Jan 2001, In : Drug Metabolism and Drug Interactions. 18, 3-4, p. 263-278 16 p.

Research output: Contribution to journalArticle

Citrus paradisi
Cytochrome P-450 CYP3A
Ketoconazole
Clozapine
Isoenzymes
29 Citations (Scopus)

Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability

Lane, H. Y., Jann, M. W., Chang, Y. C., Chiu, C. C., Huang, M. C., Lee, S. H. & Chang, W. H., 1 Jan 2001, In : Journal of Clinical Psychiatry. 62, 10, p. 812-817 6 p.

Research output: Contribution to journalArticle

Citrus paradisi
Clozapine
Eating
Cytochrome P-450 CYP3A
Cytochrome P-450 CYP1A2
80 Citations (Scopus)

Seville (sour) orange juice: Synephrine content and cardiovascular effects in normotensive adults

Penzak, S. R., Jann, M. W., Cold, J. A., Hori, Y. Y., Desai, H. D. & Gurley, B. J., 1 Jan 2001, In : Journal of Clinical Pharmacology. 41, 10, p. 1059-1063 5 p.

Research output: Contribution to journalArticle

Synephrine
Octopamine
Eating
Hemodynamics
Nasal Decongestants
172 Citations (Scopus)

Smoking in patients receiving psychotrophic medications: A pharmacokinetic perspective

Desai, H. D., Seabolt, J. & Jann, M. W., 1 Jan 2001, In : CNS Drugs. 15, 6, p. 469-494 26 p.

Research output: Contribution to journalReview article

Pharmacokinetics
Smoking
Smoke
Tobacco Products
Bupropion

The Impact of Cloning in Pharmaceutical Products and for Human Therapeutics

Jann, M. W., Shirley, K. L. & Falek, A., 1 Jan 2001, In : Global Bioethics. 14, 2-3, p. 47-51 5 p.

Research output: Contribution to journalArticle

Open Access
pharmaceutical
Organism Cloning
Pharmaceutical Preparations
drug
Disease
2000

An international symposium on psychopharmacology and ethnicity

Jann, M. W. & Montane Jaime, L. K., 1 Jan 2000, In : Drug Metabolism and Drug Interactions. 16, 1, p. 13-14 2 p.

Research output: Contribution to journalArticle

Psychopharmacology
29 Citations (Scopus)

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

VanDenBerg, C. M., Kazmi, Y. & Jann, M. W., 1 Jan 2000, In : Drugs and Aging. 16, 2, p. 123-138 16 p.

Research output: Contribution to journalReview article

Cholinesterase Inhibitors
Alzheimer Disease
Therapeutics
Drug Interactions
Population
31 Citations (Scopus)

Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

Aitchison, K. J., Jann, M. W., Zhao, J., Sakai, T., Zaher, H., Wolff, K., Collier, D., Kerwin, R. W. & Gonzalez, F. J., 1 Jan 2000, In : Journal of Psychopharmacology. 14, 4, p. 353-359 7 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP1A2
Clozapine
Pharmacokinetics
Area Under Curve
Myoclonus